Path: utzoo!utgpu!watserv1!watmath!uunet!snorkelwacker!mintaka!yale!cmcl2!mcclb0!smith From: smith@mcclb0.med.nyu.edu Newsgroups: bionet.molbio.genbank Subject: Re: GenBank software Message-ID: <6948.26c115fd@mcclb0.med.nyu.edu> Date: 9 Aug 90 11:51:25 GMT References: <9008081410.AA02507@alw.nih.gov> Organization: NYU Medical Center, New York, NY, USA Lines: 30 In article <9008081410.AA02507@alw.nih.gov>, CZJ@CU.NIH.GOV writes: > As one of the Project Officers of the GenBank Contract, I thought it > would be appropriate to respond to some of the issues raised by Dan > Davison in his "I must have been out of the room" messages. ... > Despite this position, it is obvious that some software, i.e. Jim > Fickett's program to translate GenBank is in use by GenBank and will > have to be modified to parse the new features table. Although it is > perfectly feasible to distribute this program, the problem for GenBank > is one of support. There is nothing morally wrong in distributing a program and saying that it is being provided as an example to aid development, and that it is distributed 'as-is'. This eliminates the support issue. If people have questions, they can post them to this, or some other list, for resolution. No one HAS to respond. Everyone can benefit from this, even the people at GenBank who may pick up an idea or two. I think it is important to emphasize the concept of a 'community of peers'. People should bee free to make good-faith 'submissions' of program, even if it has drawbacks they are aware of. The community then decides whether it is able to use it. The individual's choice. It benefits no one to withhold a program when the sole reason for doing so is that they cannot provide 'phone support. +---------------------------------------------------------------------------+ |Ross Smith, Cell Biology, NYU Medical Center, 550 First Ave., NYC, 10016| |Phone: (212) 340-5356: FAX: (212) 340-8139 (Alternate NYUMC) (212) 340-7190| |E-Mail: SMITH@NYUMED.BITNET (BITNET), SMITH@MCCLB0.MED.NYU.EDU (Internet)| +---------------------------------------------------------------------------+